Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 2209K) PPT slides of all figures Related biobytes podcast Correction (v205,p1505) Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Piconese, S. Articles by Colombo, M. P. Search for Related Content PubMed PubMed Citation Articles by Piconese, S. Articles by Colombo, M. P. Related Collections Related In this Issue article Social Bookmarking                            What's this?

Immunotherapy and Gene Therapy Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy

CORRESPONDENCE Mario P. Colombo: mario.colombo{at}istitutotumori.mi.it

Regulatory T (T reg) cells are the major obstacle to cancer immunotherapy, and their depletion promptly induces conversion of peripheral precursors into T reg cells. We show that T reg cells can be functionally inactivated by OX40 triggering. In tumors, the vast majority of CD4⁺ T cells are Foxp3⁺ and OX40^bright. However, intratumor injection of the agonist anti-OX40 monoclonal antibody (mAb) OX86, but not anti-CD25 mAb, induces tumor rejection in 80% of mice, an effect that is abrogated by CD8 depletion. Upon intratumor OX40 triggering, increased numbers of infiltrating dendritic cells (DCs) migrate to draining lymph nodes and generate a new wave of tumor-specific cytotoxic T lymphocytes, as detected by tetramer and CD44 staining of node CD8⁺ T lymphocytes. Tumor-bearing Rag1-knockout (KO) mice reconstituted with OX40-deficient T reg cells and wild-type (WT) effector T cells, or the reciprocal combination, showed that both T reg and effector T cells must be triggered via OX40 for the tumor to be rejected. Accordingly, WT but not OX40-KO mice receiving intratumor coinjection of OX86 and ovalbumin protein were able to revert tumor-induced tolerization of adoptively transferred OX40-competent OTII T lymphocytes. In conclusion, OX40-mediated inactivation of T reg cell function unleashes nearby DCs, allowing them to induce an adaptive immune response. In addition, the known OX40-dependent delivery of fitness signals to activated T cells is boosted by concurrent T reg cell inhibition. OX40 triggering thus has multiple effects that converge to mediate tumor rejection.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related In this Issue article

OX40: a win–win path to tumor immunity

Caitlin Sedwick
J. Exp. Med. 2008 205: 742. [Full Text] [PDF]

This article has been cited by other articles:

• Houot, R., Goldstein, M. J., Kohrt, H. E., Myklebust, J. H., Alizadeh, A. A., Lin, J. T., Irish, J. M., Torchia, J. A., Kolstad, A., Chen, L., Levy, R. (2009). Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion. Blood 114: 3431-3438 [Abstract] [Full Text]  
• Piconese, S., Gri, G., Tripodo, C., Musio, S., Gorzanelli, A., Frossi, B., Pedotti, R., Pucillo, C. E., Colombo, M. P. (2009). Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 114: 2639-2648 [Abstract] [Full Text]  
• Wang, W., Lau, R., Yu, D., Zhu, W., Korman, A., Weber, J. (2009). PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells. Int Immunol 21: 1065-1077 [Abstract] [Full Text]  
• Peggs, K. S., Quezada, S. A., Chambers, C. A., Korman, A. J., Allison, J. P. (2009). Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. JEM 206: 1717-1725 [Abstract] [Full Text]  
• Barcia, C. Jr, Gomez, A., Gallego-Sanchez, J. M., Perez-Valles, A., Castro, M. G., Lowenstein, P. R., Barcia, C. Sr, Herrero, M.-T. (2009). Infiltrating CTLs in Human Glioblastoma Establish Immunological Synapses with Tumorigenic Cells. Am. J. Pathol. 175: 786-798 [Abstract] [Full Text]  
• Sharma, M. D., Hou, D.-Y., Liu, Y., Koni, P. A., Metz, R., Chandler, P., Mellor, A. L., He, Y., Munn, D. H. (2009). Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 113: 6102-6111 [Abstract] [Full Text]  
• Zhao, B., Song, A., Haque, R., Lei, F., Weiler, L., Xiong, X., Wu, Y., Croft, M., Song, J. (2009). Cooperation between Molecular Targets of Costimulation in Promoting T Cell Persistence and Tumor Regression. J. Immunol. 182: 6744-6752 [Abstract] [Full Text]  
• Sharma, R. K., Elpek, K. G., Yolcu, E. S., Schabowsky, R.-H., Zhao, H., Bandura-Morgan, L., Shirwan, H. (2009). Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors. Cancer Res. 69: 4319-4326 [Abstract] [Full Text]  
• Hirschhorn-Cymerman, D., Rizzuto, G. A., Merghoub, T., Cohen, A. D., Avogadri, F., Lesokhin, A. M., Weinberg, A. D., Wolchok, J. D., Houghton, A. N. (2009). OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis. JEM 206: 1103-1116 [Abstract] [Full Text]  
• Houot, R., Levy, R. (2009). T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy. Blood 113: 3546-3552 [Abstract] [Full Text]  
• Ruby, C. E., Weinberg, A. D. (2009). OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age. J. Immunol. 182: 1481-1489 [Abstract] [Full Text]  
• Burrell, B. E., Lu, G., Li, X. C., Bishop, D. K. (2009). OX40 Costimulation Prevents Allograft Acceptance Induced by CD40-CD40L Blockade. J. Immunol. 182: 379-390 [Abstract] [Full Text]  
• Ahmadzadeh, M., Felipe-Silva, A., Heemskerk, B., Powell, D. J. Jr, Wunderlich, J. R., Merino, M. J., Rosenberg, S. A. (2008). FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions. Blood 112: 4953-4960 [Abstract] [Full Text]  
• Golovina, T. N., Mikheeva, T., Suhoski, M. M., Aqui, N. A., Tai, V. C., Shan, X., Liu, R., Balcarcel, R. R., Fisher, N., Levine, B. L., Carroll, R. G., Warner, N., Blazar, B. R., June, C. H., Riley, J. L. (2008). CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function. J. Immunol. 181: 2855-2868 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS